Document Type
Article
Abstract
The aim of this study was to conduct a survey of the Candida species associated with COVID-19 viral infection in 150 patients who were admitted to the intensive care unit (ICU) in Al-Diwaniyah Teaching Hospital in Al-Diwaniyah City, Iraq, for a five-month period from October 2021 to February 2022. The results indicated the dominance of Candida spp. over the rest of the isolated fungal species, with 97 isolates (64.66%). C. albicans was shown to be the most abundant species with a percentage of 55.67 percent (P 0.05), compared to the other Candida species that were isolated (Candida tropicalis 13.4 percent, Candida glabrata 12 percent, Candida krusie and Candida parapsilosis with 9.28 percent). In addition, we brought attention to the excellent action of the antifungals amphotericin B, itraconazole, and voriconazole, all of which have a high susceptibility rate.
Keywords
COVID-19, Candidiasis, Antifungal, AmphotericinB, Itraconazole, Voriconazole
Recommended Citation
Alkhuzaie, Mohammed Mudhafar and Jasim, Neeran Obied
(2023)
"Candida spp. associated with COVID-19 and its Susceptibility to some Antifungals,"
Al-Qadisiyah Journal of Pure Science: Vol. 28
:
No.
1
, Article 3.
Available at:
https://doi.org/10.29350/2411-3514.1002
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Included in
Biology Commons, Chemistry Commons, Computer Sciences Commons, Environmental Sciences Commons, Geology Commons, Mathematics Commons, Nanotechnology Commons
